These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
199 related items for PubMed ID: 29495975
21. Knockdown of LncRNA-XIST Suppresses Proliferation and TGF-β1-Induced EMT in NSCLC Through the Notch-1 Pathway by Regulation of miR-137. Wang X, Zhang G, Cheng Z, Dai L, Jia L, Jing X, Wang H, Zhang R, Liu M, Jiang T, Yang Y, Yang M. Genet Test Mol Biomarkers; 2018 Jun; 22(6):333-342. PubMed ID: 29812958 [Abstract] [Full Text] [Related]
22. LncRNA H19/miR-29b-3p/PGRN Axis Promoted Epithelial-Mesenchymal Transition of Colorectal Cancer Cells by Acting on Wnt Signaling. Ding D, Li C, Zhao T, Li D, Yang L, Zhang B. Mol Cells; 2018 May 31; 41(5):423-435. PubMed ID: 29754471 [Abstract] [Full Text] [Related]
23. LncRNA-XIST promotes the oxidative stress-induced migration, invasion, and epithelial-to-mesenchymal transition of osteosarcoma cancer cells through miR-153-SNAI1 axis. Wen JF, Jiang YQ, Li C, Dai XK, Wu T, Yin WZ. Cell Biol Int; 2020 Oct 31; 44(10):1991-2001. PubMed ID: 32515520 [Abstract] [Full Text] [Related]
24. LncRNA-ANCR down-regulation suppresses invasion and migration of colorectal cancer cells by regulating EZH2 expression. Yang ZY, Yang F, Zhang YL, Liu B, Wang M, Hong X, Yu Y, Zhou YH, Zeng H. Cancer Biomark; 2017 Oct 31; 18(1):95-104. PubMed ID: 27983539 [Abstract] [Full Text] [Related]
26. LncRNA XIST promotes pancreatic cancer migration, invasion and EMT by sponging miR-429 to modulate ZEB1 expression. Shen J, Hong L, Yu D, Cao T, Zhou Z, He S. Int J Biochem Cell Biol; 2019 Aug 31; 113():17-26. PubMed ID: 31163263 [Abstract] [Full Text] [Related]
27. The carcinogenic complex lncRNA DUXAP8/EZH2/LSD1 accelerates the proliferation, migration and invasion of colorectal cancer. Gong A, Huang Z, Ge H, Cai Y, Yang C. J BUON; 2019 Aug 31; 24(5):1830-1836. PubMed ID: 31786844 [Abstract] [Full Text] [Related]
30. LncRNA XIST sponges microRNA-448 to promote malignant behaviors of colorectal cancer cells via regulating GRHL2. Yan Z, Li J, Guo J, He R, Xing J. Funct Integr Genomics; 2022 Oct 31; 22(5):977-988. PubMed ID: 35725976 [Abstract] [Full Text] [Related]
31. LncRNA MALAT1 promotes colorectal cancer development by sponging miR-363-3p to regulate EZH2 expression. Xie JJ, Li WH, Li X, Ye W, Shao CF. J Biol Regul Homeost Agents; 2019 Oct 31; 33(2):331-343. PubMed ID: 30972996 [Abstract] [Full Text] [Related]
33. LncRNA OGFRP1 promotes angiogenesis and epithelial-mesenchymal transition in colorectal cancer cells through miR-423-5p/CTCF axis. Dong H, Liu Q, Chen C, Lu T, Xu K. Immunobiology; 2022 Mar 31; 227(2):152176. PubMed ID: 35066433 [Abstract] [Full Text] [Related]
34. The lncRNA FEZF1-AS1 Promotes the Progression of Colorectal Cancer Through Regulating OTX1 and Targeting miR-30a-5p. Li J, Zhao LM, Zhang C, Li M, Gao B, Hu XH, Cao J, Wang GY. Oncol Res; 2020 Feb 07; 28(1):51-63. PubMed ID: 31270006 [Abstract] [Full Text] [Related]
37. Long noncoding RNA XIST increases the aggressiveness of laryngeal squamous cell carcinoma by regulating miR-124-3p/EZH2. Xiao D, Cui X, Wang X. Exp Cell Res; 2019 Aug 15; 381(2):172-178. PubMed ID: 31071316 [Abstract] [Full Text] [Related]
38. Linc00883 affects colorectal cancer through miR-577/FKBP14 axis: a novel mechanism for regulating colorectal cancer cell proliferation, invasion, and migration. Bai Y, Li L, Zhang Z. Cell Cycle; 2022 Nov 15; 21(22):2403-2416. PubMed ID: 35833665 [Abstract] [Full Text] [Related]
39. LINC00174 Facilitates Proliferation and Migration of Colorectal Cancer Cells via MiR-3127-5p/ E2F7 Axis. Ma Y, Li Y, Tang Y, Tang N, Wang D, Li X. J Microbiol Biotechnol; 2021 Aug 28; 31(8):1098-1108. PubMed ID: 34226413 [Abstract] [Full Text] [Related]
40. Atractylenolide II reverses the influence of lncRNA XIST/miR-30a-5p/ROR1 axis on chemo-resistance of colorectal cancer cells. Zhang R, Wang Z, Yu Q, Shen J, He W, Zhou D, Yu Q, Fan J, Gao S, Duan L. J Cell Mol Med; 2019 May 28; 23(5):3151-3165. PubMed ID: 30907503 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]